Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

Condition:   Alport Syndrome, X-Linked Interventions:   Drug: Hydroxychloroquine Sulfate 100 milligram (mg) Tab;   Drug: Benazepril hydrochloride 10 milligram (mg) Tab Sponsor:   Shanghai Children's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials